SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas

Arianna L Kim1, Jung Ho Back1, Sandeep C Chaudhary2

  • 1Department of Dermatology, Columbia University Medical Center, New York, New York, USA.

Insights

Targeting the SOX9-mTOR axis offers a new strategy for basal cell carcinoma (BCC) treatment. This pathway bypasses current therapies, potentially improving outcomes for patients with basal cell nevus syndrome.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Current smoothened targeted therapies for basal cell nevus syndrome (BCNS) face challenges with tumor recurrence and resistance.
  • Novel therapeutic strategies targeting downstream components of the Hedgehog pathway are needed for improved efficacy and therapeutic index.

Purpose of the Study:

  • To investigate the role of Sry-related high mobility group box 9 (SOX9) in basal cell carcinoma (BCC) growth.
  • To elucidate the mechanistic link between the Hedgehog and mammalian target of rapamycin (mTOR) pathways in BCC.
  • To evaluate the SOX9-mTOR axis as a potential therapeutic target downstream of smoothened.

Main Methods:

  • Sequence motif analysis identified SOX9-responsive elements in the mTOR promoter.
  • SOX9 knockdown and smoothened inhibition (itraconazole, vismodegib) were performed in murine BCC cells.
  • mTOR expression, downstream target phosphorylation, and cellular proliferation were assessed.
  • Pharmacologic mTOR inhibition with rapamycin was tested in a UV-induced BCC mouse model (Ptch1+/-/SKH-1).

Main Results:

  • SOX9 was found to occupy and induce transcriptional activity of the mTOR promoter in murine BCC cells.
  • SOX9 knockdown and smoothened inhibition reduced mTOR expression and downstream signaling, decreasing BCC cell proliferation.
  • Rapamycin suppressed UV-induced BCC growth in a mouse model mimicking BCNS.
  • Demonstrated a direct mechanistic link between Hedgehog and mTOR pathways driving BCC growth via SOX9.

Conclusions:

  • Hedgehog signaling converges on mTOR through SOX9 in BCC.
  • The SOX9-mTOR axis represents a viable therapeutic target downstream of smoothened.
  • Targeting this axis could enhance tumor elimination in patients with BCC and BCNS.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Master Transcription Regulators02:23

Master Transcription Regulators

2.8K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

2.6K
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
783
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K